Patients and consumers worried about dental amalgams mercury content and its risks flood an FDA docket seeking input on Patient Preference Information...
Federal Register notice: FDA makes available a draft guidance entitled Testing for Biotin Interference in In Vitro Diagnostic Devices.
Merck, Eli Lilly and Amgen sue HHS to block a rule that would require drug prices be included in direct-to-consumer ads.
Federal Register notice: FDA withdraws approval of 12 ANDAs from multiple applicants after they notified the agency that the drug products were no lon...
Federal Register notice: FDA requests that any consumer organizations interested in participating in selecting voting or nonvoting consumer representa...
Federal Register notice: FDA announces a 7/31 Psychopharmacologic Drugs Advisory Committee meeting to discuss an Intra-Cellular Therapies schizophreni...
At FDAs request, U.S. marshals seize more than 300,000 dietary supplement containers, including tablets, capsules, and teas from Life Rising Corp.
Following adverse events, including one death. and incorrect results, FDA publishes a draft guidance on biotin testing in in vitro diagnostic tests.